Dr. Steven Millership

Biography

Dr. Steven Millership completed his PhD in Cell Biology at Cardiff University in 2012, where he demonstrated SNARE-complex promoting potential of synucleins in neurons and white adipocytes. His postdoctoral work at the MRC London Institute of Medical Sciences centered on determining the function of neuronatin, an imprinted gene previously implicated in obesity and type 2 diabetes. His work described a fundamental new mechanism involved in the synthesis of insulin in pancreatic beta cells, highlighting the control of insulin prepeptide cleavage by the endoplasmic reticulum signal peptidase apparatus mediated by neuronatin. In February 2020, he was awarded the Wellcome Trust ISSF Springboard Fellowship and joined the Section of Cell Biology and Functional Genomics in the Department of Metabolism, Digestion, and Reproduction at Imperial College London, supported by the Diabetes Research and Wellness Foundation project grant and Society for Endocrinology Early Career Grant. Dr. Millership leads modules in the MSc Applied Genomics programme and serves as a deputy module lead for the BSc Medical Biosciences. His research focuses on controlling pancreatic beta cell function through epigenetic pathways, impacting islet function under normal conditions and in type 2 diabetes. He has also been recognized with the New Investigator Prize Lecture at the University of Toronto and the Non-Clinical Early Career Prize Lecture from the Society for Endocrinology. Dr. Millership is an early career editor for the Journal of Endocrinology and the Journal of Molecular Endocrinology, and he is part of the Society for Endocrinology Leadership Development Programme from 2022 to 2025.

Research Interests